Considering what is known about increased EGFR and ANO expression in cancer, particularly in gliomas, further investigation into how calcium signalling may contribute to drug resistance and cellular plasticity in brain tumour progression is warranted. This evidence concerns the gene EGFR and central nervous system cancer.